-
Pancreatic Cancer Sequencing Initiative
Study
EGAS00001000343
-
Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency
Study
EGAS00001002200
-
Rapid response of APC/TP53/KRAS mutated stage IV colorectal cancer under FOLFIRI + Bevacizumab detected by liquid biopsy: a case report
Study
EGAS00001004088
-
Comparison of structural variations from 10X Genomics linked-reads and conventional Illumina short-reads sequencing
Study
EGAS00001004093
-
Sequencing of liver cancer cell lines
Study
EGAS00001002237
-
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
Study
EGAS00001004114
-
The molecular landscape of colorectal cancer (17 cases)
Study
EGAS00001002174
-
Imaging metabolic heterogeneity in breast cancer using hyperpolarized 13C-MRI
Study
EGAS00001004118
-
Most HCCs in Taiwan show the mutational signature of aristolochic acid
Study
EGAS00001002301
-
Metastatic Adult Pancreatoblastoma: Multimodal Treatment and Molecular Characterization of a Very Rare Disease (NCT MASTER)
Study
EGAS00001004157
-
Chromatin run-on and RNA sequencing of fibrolamellar carcinoma
Study
EGAS00001004169
-
The_Causes_of_Clonal_Blood_Cell_Disorders_Study___SCOR_Custom
Study
EGAS00001002257
-
Targeted sequencing of breast cancers with germline BRCA1/2 mutations
Study
EGAS00001004182
-
CELM
Study
EGAS00001002261
-
Integrative analysis of whole genome sequencing, RNA sequencing and methylome array of 20 carcinosarcomas.
Study
EGAS00001002271
-
pancreatic ductal adenocarcinoma exomes in study: Pro-immunogenic Impact of MEK inhibition combined with an anti-CD40 immunostimulatory antibody
Study
EGAS00001004196
-
BGISEQ-500 Cancer Dataset - WGS tumour/normal pairs
Study
EGAS00001002298
-
Somatic_mutations_in_twin_breast_cancers
Study
EGAS00001002379
-
Next_gen_seq_of_eye_cancers
Study
EGAS00001002309
-
Heterogeneous Genomic Evolution and Immune Microenvironments in Metastatic Lung Cancer
Study
EGAS00001004228
-
Adult granulosa cell tumor WGS data cohort with corresponding reference germline WGS data
Study
EGAS00001004249
-
Longitudinal therapy monitoring of ALK-positive non-small cell lung cancer (copy number, cell-free DNA)
Study
EGAS00001004276
-
Dissecting intratumor heterogeneity of nodal B cell lymphoma on the transcriptional, genetic, and drug response level
Study
EGAS00001004335
-
Molecular determinants of response to PD-L1 blockade across tumor types
Study
EGAS00001004343
-
Pulldown_DNA_methylation_study_v2
Study
EGAS00001000979
-
Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
Study
EGAS00001004353
-
Whole genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
Study
EGAS00001004379
-
Bulk RNAseq gene expression of baseline tumors from metastatic urothelial bladder cancer patients (IMvigor210) and metastatic renal cell carcinoma (IMmotion150)
Study
EGAS00001004386
-
Genomic study of an AT-AML
Study
EGAS00001004392
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Whole exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer
Study
EGAS00001004486
-
RNA-seq data from 121 tumor samples with muscle invasive bladder cancer.
Study
EGAS00001004505
-
Chromosomal copy number heterogeneity predicts survival rates across cancers
Study
EGAS00001004702
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
Angiosarcoma_follow_up_study
Study
EGAS00001000405
-
Mutational signatures in head and neck cancer (H019)
Study
EGAS00001004588
-
Molecular sub-classification of hormone receptor-positive breast cancer
Study
EGAS00001004594
-
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
Study
EGAS00001000566
-
whole genome sequence data of multifocal hepatocellular carcinoma
Study
EGAS00001002338
-
In this study, we performed exon sequencing (WXS) of 80 paired Brain cancer tumors and adjacent normal tissues to identify novel potential biomarkers. We extracted mutational signatures which induce somatic mutations . Our study covers a comprehensive genetic framework that can be used in clinical trials and treatment modalities in Brain cancer.
Study
EGAS00001002352
-
CEHM
Study
EGAS00001002366
-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666
-
Genetic ancestry contributes to somatic mutations in lung cancers from admixed Latin American populations
Study
EGAS00001004752
-
Field_effect_of_healthy_and_diseased_livers
Study
EGAS00001002382
-
Low_Coverage_Sequencing_of_rare_human_histiocytic_tumour
Study
EGAS00001000768
-
Immunological hallmarks for clinical response to BCG in bladder cancer
Study
EGAS00001004764
-
ENCORE__New_Targets_for_Effective_Combination_Therapies_in_Tumors_with_Unmet_Medical_Need
Study
EGAS00001004775
-
TRACERx 100: metastatic samples
Study
EGAS00001002415
-
Myeloma_Follow_up_Pilot
Study
EGAS00001000743
-
WGS___Mutant_clone_mapping_in_normal_oesohagus_and_skin
Study
EGAS00001002416